Federal Register of Legislation - Australian Government

Primary content

PB 40 of 2023 Determinations/Health as made
This instrument amends the National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022) by removing three brands of nine pharmaceutical items that were delisted off the PBS on 1 April 2023 and 1 May 2023 as requested by the responsible persons.
Administered by: Health and Aged Care
Registered 28 Apr 2023
Tabling HistoryDate
Tabled HR09-May-2023
Tabled Senate09-May-2023
Date of repeal 08 Aug 2023
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Table of contents.

Commonwealth Coat of Arms of Australia

 

PB 40 of 2023

 

National Health (Price and Special Patient Contribution) Amendment Determination 2023 (No. 3)

I, Nikolai Tsyganov, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following Determination.

Dated        26 April 2023

NIKOLAI TSYGANOV

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health and Aged Care

 

 


Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments                                                                                           2

National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022) 2

 

 


1  Name

                   This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2023 (No. 3).

                   This instrument may also be cited as PB 40 of 2023.

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 May 2023

 

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under section 85B of the National Health Act 1953.

4  Schedules

                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.


Schedule 1Amendments

National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)

 

1.            Schedule 1 - omit entry for Atomoxetine

2.            Schedule 1 - entry for Indapamide

 

Omit

Indapamide

Tablet containing indapamide hemihydrate 1.5 mg (sustained release)

Oral

Natrilix SR

90

7.17

13.82

 

Tablet containing indapamide hemihydrate 2.5 mg

Oral

Natrilix

90

4.91

11.96

 

 

Insert

Indapamide

Tablet containing indapamide hemihydrate 1.5 mg (sustained release)

Oral

Natrilix SR

90

7.17

13.82

 

3.            Schedule 1 - omit entry for Norethisterone with ethinylestradiol